On October 24, 2008, Invalda AB has signed an agreement regarding transfer of 6 314 502 shares, i.e. 20.3 % of share capital, of Sanitas AB for the total price..
MoreCenter for Drug Administration and Research of U.S. Food and Drug Administration (FDA) after the inspection of sterile pharmaceutical finished dosage manufacturing facility in Polish pharmaceutical company Jelfa SA classified..
MoreNet profit of Vilniaus baldai AB during September 2008 was 477 thousand LTL (138 thousand EUR), September of previous year – net profit of 174 thousand LTL (51 thousand EUR). EBITDA..
MoreAt the proposal of the president, the Lithuanian Parliament (Seimas) today approved the appointment of Lina Sajytė as a member of the Securities Commission. Ms Sajytė had been working as..
MoreFollowing the Board decision of Invalda AB 75 mLTL nominal value non-public bonds were issued. This issue will be refinanced in December 2008 by issuing non-public 25 mLTL and 50 mLTL..
MoreThe Board of Invalda AB approved the draft resolutions for the Extraordinary General Meeting of shareholders to be held on. On the agenda:1. Regarding non-public LTL 25 m convertible bonds..
MoreOn October 15, 2008 the Board of Invalda AB in pursuance of the decision of the Board, dated October 13, 2008, and in order to rearrange liabilities passed the decision..
MoreThe Latvian investment management company IPAS Baltikums Asset Management, which was acquired by AB Invalda in September, is changing its name and will now be called Invalda Asset Management Latvia…
More15-10-2008 notification on transaction in issuer’s securities
More